BOTULINUM TOXIN PRE-FILLED INJECTABLE FORMULATION THAT FACILITATES DISCHARGE RATE CONTROL AND IS STABLE

Title:

BOTULINUM TOXIN PRE-FILLED INJECTABLE FORMULATION THAT FACILITATES DISCHARGE RATE CONTROL AND IS STABLE

Document Type and Number:

WIPO Patent Application WO/2021/206360

Kind Code:

A1

Abstract:

Provided is a botulinum toxin pre-filled injectable formulation that facilitates discharge rate control and is stable.

More Like This:

JP2024505490	Antiviral compositions and devices and methods of using them
WO/2009/083686	PHARMACEUTICAL COMPOSITIONS CONTAINING AT LEAST ONE PROTEINACEOUS ACTIVE INGREDIENT PROTECTED AGAINST DIGESTIVE ENZYMES
JP7300768	How to relieve joint pain

Inventors:

RHEE CHANG HOON (KR)
YUN JI HYU (KR)
PARK YOUNG SU (KR)

Application Number:

PCT/KR2021/003989

Publication Date:

October 14, 2021

Filing Date:

March 31, 2021

Export Citation:

Assignee:

MEDYTOX INC (KR)

International Classes:

A61K9/08; A61K9/00; A61K38/48; A61K47/12; A61K47/20; A61K47/22; A61K47/26; A61M5/28; A61M5/31

Domestic Patent References:

WO2001058472A2

2001-08-16

Foreign References:

Other References:

WR PEARSONDJ LIPMAN, PNAS, vol. 85, 1988, pages 2444 - 2448

Attorney, Agent or Firm:

Y.P.LEE, MOCK & PARTNERS (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: ECO-FRIENDLY NONWOVEN FABRIC, COMPOSITE NONWOVEN FABRIC, AND ARTICLE COMPRISING SAME

Next Patent: METHOD AND DEVICE FOR APPLYING OPTIMIZED PHASE ROTATION TO BROADBAND IN WIRELESS LAN SYSTEM